ONC's new ruling pushes the needle on FHIR adoption

Mati Gill, AION Labs CEO, provides an update on the company’s nine AI-enabled drug discovery portfolio companies, how the organizations are making an impact in life sciences and what’s next for AION, including exploring quantum technologies.

Practice management requires a human in the loop for the use of artificial intelligence, as well as a "human on the loop" that assures the quality of AI agents handling automated processes, says Michael Clark, Onpoint Healthcare Partners president.

The Philadelphia health system has committed to returning 10 million hours back to patient care over the next three years using AI, says Dr. Baligh Yehia, president of Jefferson Health.